Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              GA Depot (Long-acting IM Injection of Glatiramer Acetate) Presents Improved Safety and Tolerability Features: Results from a Multinational, Double-blind, Placebo-controlled Phase III Study in Subjects with Relapsing Forms of Multiple Sclerosis

              Author:Miller, Aaron   Popper, Laura   Kolb, Hadar   Kimelman, Nadav   Rubnov, Shai   Danon, Uri   Marom, Ehud   

              Session Name:P8: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 1  

              Topic:Multiple Sclerosis  

              Program Number:P8.018  

              Author Institution:Mt Sinai School Of Med, New York, NY  Mapi Pharma Ltd., Ness Ziona, Israel  Souraski Medical Center, Tel Aviv, Israel  Mapi Pharma Ltd, Ness Ziona, Israel